BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 31469400)

  • 1. Management Strategies and Patient Selection After a Hospital Funding Reform for Prostate Cancer Surgery in Canada.
    Wettstein MS; Palmer KS; Kulkarni GS; Paterson JM; Ling V; Lapointe-Shaw L; Li AH; Brown A; Taljaard M; Ivers N
    JAMA Netw Open; 2019 Aug; 2(8):e1910505. PubMed ID: 31469400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of quality-based procedure hospital funding reform in Ontario, Canada: An interrupted time series study.
    Li AH; Palmer KS; Taljaard M; Paterson JM; Brown A; Huang A; Marani H; Lapointe-Shaw L; Pincus D; Wettstein MS; Kulkarni GS; Wasserstein D; Ivers N
    PLoS One; 2020; 15(8):e0236480. PubMed ID: 32813687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathological stage distribution in patients treated with radical prostatectomy reflecting the need for protocol-based active surveillance: results from a contemporary European patient cohort.
    Seiler D; Randazzo M; Klotz L; Grobholz R; Baumgartner M; Isbarn H; Recker F; Kwiatkowski M
    BJU Int; 2012 Jul; 110(2):195-200. PubMed ID: 22093744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active Surveillance Versus Radical Prostatectomy in Favorable-risk Localized Prostate Cancer.
    Thomsen FB; Røder MA; Jakobsen H; Langkilde NC; Borre M; Jakobsen EB; Frey A; Lund L; Lunden D; Dahl C; Brasso K
    Clin Genitourin Cancer; 2019 Aug; 17(4):e814-e821. PubMed ID: 31196798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns-of-care and health economic analysis of robot-assisted radical prostatectomy in the Australian public health system.
    Basto M; Sathianathen N; Te Marvelde L; Ryan S; Goad J; Lawrentschuk N; Costello AJ; Moon DA; Heriot AG; Butler J; Murphy DG
    BJU Int; 2016 Jun; 117(6):930-9. PubMed ID: 26350758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radical retropubic prostatectomy for localized carcinoma of the prostate in a large metropolitan hospital: changing trends over a 10-year period (1984-1994). Dallas Outcomes Research Group for Urological Disorders.
    Litwiller SE; Djavan B; Klopukh BV; Richier JC; Roehrborn CG
    Urology; 1995 May; 45(5):813-22. PubMed ID: 7747373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health-related quality of life in active surveillance and radical prostatectomy for low-risk prostate cancer: a prospective observational study (HAROW - Hormonal therapy, Active Surveillance, Radiation, Operation, Watchful Waiting).
    Ansmann L; Winter N; Ernstmann N; Heidenreich A; Weissbach L; Herden J
    BJU Int; 2018 Sep; 122(3):401-410. PubMed ID: 29603553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis.
    Moschini M; Zaffuto E; Karakiewicz PI; Andrea DD; Foerster B; Abufaraj M; Soria F; Mattei A; Montorsi F; Briganti A; Shariat SF
    Eur Urol; 2019 Feb; 75(2):319-328. PubMed ID: 30293908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in Radical Prostatectomy Risk Group Distribution in a European Multicenter Analysis of 28 572 Patients: Towards Tailored Treatment.
    van den Bergh R; Gandaglia G; Tilki D; Borgmann H; Ost P; Surcel C; Valerio M; Sooriakumaran P; Salomon L; Briganti A; Graefen M; van der Poel H; de la Taille A; Montorsi F; Ploussard G;
    Eur Urol Focus; 2019 Mar; 5(2):171-178. PubMed ID: 28801241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limitations in Predicting Organ Confined Prostate Cancer in Patients with Gleason Pattern 4 on Biopsy: Implications for Active Surveillance.
    Perlis N; Sayyid R; Evans A; Van Der Kwast T; Toi A; Finelli A; Kulkarni G; Hamilton R; Zlotta AR; Trachtenberg J; Ghai S; Fleshner NE
    J Urol; 2017 Jan; 197(1):75-83. PubMed ID: 27457260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.
    Vargas C; Kestin LL; Weed DW; Krauss D; Vicini FA; Martinez AA
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):714-24. PubMed ID: 15708249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of repeat prostate biopsies on functional outcomes after radical prostatectomy.
    Rosenbaum CM; Mandel P; Tennstedt P; Preisser F; Marks P; Chun FK; Graefen M; Tilki D; Salomon G
    Urol Oncol; 2018 Mar; 36(3):91.e17-91.e22. PubMed ID: 29246393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Outcomes after Deferred Radical Prostatectomy in Men Initially Treated with Active Surveillance.
    Godtman RA; Schafferer M; Pihl CG; Stranne J; Hugosson J
    J Urol; 2018 Oct; 200(4):779-785. PubMed ID: 29730198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generalizability of the Prostate Cancer Intervention Versus Observation Trial (PIVOT) Results to Contemporary North American Men with Prostate Cancer.
    Dalela D; Karabon P; Sammon J; Sood A; Löppenberg B; Trinh QD; Menon M; Abdollah F
    Eur Urol; 2017 Apr; 71(4):511-514. PubMed ID: 27638094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer and Leukemia Group B (CALGB) 90203: a randomized phase 3 study of radical prostatectomy alone versus estramustine and docetaxel before radical prostatectomy for patients with high-risk localized disease.
    Eastham JA; Kelly WK; Grossfeld GD; Small EJ;
    Urology; 2003 Dec; 62 Suppl 1():55-62. PubMed ID: 14747042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is active surveillance a safe alternative in the management of localized prostate cancer? Pathological features of radical prostatectomy specimens in potential candidates for active surveillance.
    Norman Z; Militza P; Andres F; Daniela F; Alejandro M; Catherine S; Juan F
    Int Braz J Urol; 2014; 40(2):154-9. PubMed ID: 24856482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sexual function with localized prostate cancer: active surveillance vs radical therapy.
    van den Bergh RC; Korfage IJ; Roobol MJ; Bangma CH; de Koning HJ; Steyerberg EW; Essink-Bot ML
    BJU Int; 2012 Oct; 110(7):1032-9. PubMed ID: 22260273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Definitive external-beam radiotherapy versus radical prostatectomy in clinically localized high-risk prostate cancer: a retrospective study.
    Andic F; Izol V; Gokcay S; Arslantas HS; Bayazit Y; Coskun H; Tansug MZ; Sertdemir Y
    BMC Urol; 2019 Jan; 19(1):3. PubMed ID: 30611260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radical prostatectomy vs radiotherapy vs observation among older patients with clinically localized prostate cancer: a comparative effectiveness evaluation.
    Sun M; Sammon JD; Becker A; Roghmann F; Tian Z; Kim SP; Larouche A; Abdollah F; Hu JC; Karakiewicz PI; Trinh QD
    BJU Int; 2014 Feb; 113(2):200-8. PubMed ID: 23937636
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.